- Stocks Telegraph Morning
- Posts
- Dec - 01 - NH - Morning Newsletter (with survey at top and bottom)
Dec - 01 - NH - Morning Newsletter (with survey at top and bottom)
🔥 Ignite Your Portfolio – 4 Stocks on the Rise!
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!
Stock futures exhibited a mixed performance on Friday morning after the Dow Jones Industrial Average achieved a new high in 2023 and concluded its best month in over a year. Futures linked to the 30-stock index slightly increased by 49 points, or 0.1%, while S&P 500 futures and Nasdaq-100 futures remained nearly unchanged. Investors were anticipating remarks from Federal Reserve Chair Jerome Powell later in the day. Powell is scheduled to speak in a fireside chat at 11 a.m. ET at Spelman College. The substantial rally in November was partly attributed to traders perceiving the Fed as finished with rate hikes, and there was speculation about potential rate cuts in the first half of the coming year. The Fed is set to make rate decisions on Dec. 13. Looking forward, earnings reports from Dominion Energy, Gartner, and Cardinal Health are anticipated on Friday, along with Construction Spending data for October and ISM Manufacturing data for November.
This Strange Plant Could Lead to a BIG Opportunity for Investors
A little-known company is developing a new nanotechnology that
instantly repels viruses
, bacteria, and even
the strongest superbugs
. It's inspired by the "sacred" lotus plant with nanoscopic features a BILLION times smaller than we can see with the naked eye.
You have the opportunity to get in on this company early –
before
it potentially starts down the path to commercialization.
Sponsored
Today Top Movers
Biora Therapeutics Inc (BIOR) stock soared 45.16% to $1.8 in the pre-market trading after announcing FDA clearance of IND application for Drug/Device combination BT-600 targeting treatment of Ulcerative Colitis.
Altimmune Inc (NASDAQ: ALT) shares are trading up 36.08% at $4.3 at the time of writing following the release of positive topline results from MOMENTUM 48-Week phase 2 obesity trial of Pemvidutide.
Samsara Inc (IOT) grew over 15.29% at $31.75 in pre-market trading today after reporting that it was recognized by Frost & Sullivan as the 2023 Company of the Year for Commercial Telematics solutions.
Elastic N.V (ESTC), a Software - Application company, rose about 18.59% at $95.3 in pre-market trading Friday. The company announced that it has completed the acquisition of Opster, the creators of AutoOps and other tools used to help users get more out of their Elastic deployments.
The lazy way to trade the same stock for repeated profits
If I told you, there was a simple strategy, that pays out up to $1,463 in extra income every single week (even in THIS wild market), you probably wouldn't believe me. And if I told you that same strategy hasn't closed out a losing trade in well over 5 years you'd likely think I was nuts as it sounds "too good to be true."
Sponsored
Top Upgrades & Downgrades
UBS turned bullish on Johnson & Johnson (JNJ), upgrading the stock to Buy and assigning a $180 price target, representing potential upside of 15.38% from Thursday's close.
Chemours Company (CC) has won the favor of RBC Capital's equity research team. The firm upgraded the shares from Sector Perform to Outperform and moved their price target to $40, suggesting 42.25% additional upside for the stock.
Norfolk Southern Corp. (NSC) received an upgrade from analysts at BofA. They changed their rating on NSC to Buy from Neutral in a recently issued research note.
Earlier Friday Citigroup reduced its rating on Spotify Technology S.A. (SPOT) stock to Neutral from Buy and assigned the price target to $190.
Guggenheim analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Immunogen, Inc. (IMGN) has been changed to Neutral from Buy and the new price target is set at $31.
Analysts at Morgan Stanley downgraded Alibaba Group Holding Ltd ADR (BABA)'s stock to Equal-Weight from Overweight Friday.
ChatGPT admits...
"[Industry X] will grow at the same rate as the AI industry..."
But these stocks sell for up to 97% less.
Sponsored
Latest Insider Activity
Exxon Mobil Corp. (XOM) Director UBBEN JEFFREY W announced the sale of shares taking place on Nov 28 at $104.06 for some 2,077,000 shares. The total came to more than $216.13 million.
UiPath Inc (PATH) Director Wong Rich sold on Nov 29 a total 100,000 shares at $19.98 on average. The insider’s sale generated proceeds of almost $2.0 million.
Staar Surgical Co. (STAA) 10% Owner BROADWOOD PARTNERS, L.P. declared the purchase of shares taking place on Nov 30 at $31.42 for some 177,707 shares. The transaction amount was around $5.58 million.
Bristol-Myers Squibb Co. (BMY) Chief Executive Officer BOERNER CHRISTOPHER S. bought on Nov 28 a total 3,071 shares at $48.86 on average. The purchase cost the insider an estimated $150,049.
Your Financial Advisor Doesn't Even Realize This Could Happen
The bad news is your financial advisor is leaving your portfolio vulnerable to a big bubble popping. The good news is that there are 3 simple steps you can take to protect your portfolio and profit in the next six months. Jason has called crashes like this before and he is unveiling a 3-step plan for surviving this crash and potentially profiting big when the pop does happen.
Sponsored
Important Earnings
Top US earnings releases scheduled for today include Genesco Inc. (NYSE:GCO). It will announce its Oct 2023 financial results. The company is expected to report earnings of $0.83 per share from revenues of $588.6M in the three-month period.
Analysts expect Fusion Fuel Green Ltd (NASDAQ:HTOO) to report a net income (adjusted) of -$0.23 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Sep 2023 is predicted to come in at $4.9M.
Science Applications International Corp. (SAIC), due to announce earnings after the market closes today, is expected to report earnings of $1.69 per share from revenues of $1.79B recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.